Subchronic lead exposure, immunotoxicology and increased disease resistance in Japanese quail (Corturnix coturnix japonica).
The present study investigated the effects of lead (Pb) on immune responses in quail (Coturnix coturnix japonica) and the pathological impact of exposure to an infectious agent (E. coli O2). Fifty-four, 4-week-old quail were exposed to lead acetate in drinking water at 5 or 50 ppm. All birds were vaccinated with Newcastle Vaccine (NDV) during the third week of contaminant (Pb) exposure. In the fourth week, several arms of the immune response were tested using the T cell based phytohemagglutinin (PHA) skin test, the B cell mediated antibody response to NVD, and the chemiluminescence assay measuring innate immunity. Immunohistochemistry (IHC) was used to determine the expression of toll like receptor-3 (TLR-3) in the bursa of Fabricius. In the fifth week, quail were challenged with 200 μL of E. coli O2 (1×10(4) colony forming units (CFU)/mL). No clinical signs of Pb toxicity were observed. Morbidity/mortality subsequent to E. coli exposure was lowest in the high exposure group (27.8%) compared to low exposure (44.4%) and control (55.5%) groups. There was no difference in the T-cell-mediated PHA response, primary or secondary immune response or the innate response in Pb exposed groups; however, bursal TLR-3 increased (p<0.05) with higher Pb exposure. No evidence supported that subchronic Pb exposure was immunotoxic to quail at 5 or 50 ppm in drinking water. In contrast, our results provide evidence of a hormetic effect, with Pb exposed birds having lower morbidity and better survival than controls. Subchronic Pb exposure may be immunostimulatory rather than suppressive as predicted in earlier studies based on testing individual immune parameters.
Ecosystem & Public Health, Faculty of Veterinary Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, AB, Canada T2N 4Z6. snain@ucalgary.ca
S
S
Nain
J E G
JE
Smits
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D002060:Bursa of Fabricius / Q000187:drug effects / Q000276:immunology; D003370:Coturnix / Q000276:immunology* / Q000382:microbiology / Q000502:physiology; D004927:Escherichia coli Infections / Q000276:immunology*; D007113:Immunity, Innate; D007854:Lead / Q000494:pharmacology*; D010835:Phytohemagglutinins / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D051196:Toll-Like Receptor 3 / Q000378:metabolism; D014874:Water Pollutants, Chemical / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D010835:Phytohemagglutinins; D051196:Toll-Like Receptor 3; D014874:Water Pollutants, Chemical; D007854:Lead